Trial Site Detail

 

Drug:
Imatinib
Trial:
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

CHRU Strasbourg - Hôpital Hautepierre

     
Strasbourg , 67098
France

 

Principal Investigator:
 Laure DE COCK, Dr
Contact:
 Jean-Emmanuel KURTZ, Pr +33 3 88 12 78 82 emmanuel.kurtz@chru-strasbourg.fr
Activation Status of this Site:
 Not yet activated
Notes about this Site:
CHRU Strasbourg - Hôpital Hautepierre Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.